Torii Pharmaceutical: Torii’s Views on Report from ISS, a Proxy Advisory Firm, on Proposals for Torii’s General Meeting of Shareholders

JPX · Mar 16 07:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.